Ring Therapeutics® Presents its Vector Conjugate and VectorBricks™ Manufacturing Platforms at the 29th Annual American Society of Gene & Cell Therapy Conference

B CAMBRIDGE, Mass., May 14, 2026 /PRNewswire/ — Ring Therapeutics®, a life sciences company pioneering a new class of targeted medicines, today announced new data…
posteditor
posteditor
Articles: 17424